News

Dr Suzanne Dilly discusses VAL401 license agreement.

Videos and audiocasts

ValiRx - Agreement to License VAL401

Image depicts Suzy Dilly, CEO of ValiRx

ValiRx strikes deal with Ambrose Healthcare to license late-stage cancer treatment

News roundup

ValiRx news round-up: October 2023

Zai Ahmad

Ada Lovelace Day 2023: Zai Ahmad’s journey into STEM

Inaphaea lab launch

ValiRx news roundup: September 2023

ValiRx - Q&A Session September 2023

ValiRx Q&A Session with Dr Suzanne Dilly and Dr Kevin Cox

Meet the ValiRx team Gerry Desler

Meet the ValiRx team: Gerry Desler

News roundup

ValiRx news roundup: August 2023

Microphone

Keynote speakers announced for Inaphaea’s lab launch event

Scientific Advisory Board

Meet the ValiRx Scientific Advisory Board

MediCity

Inaphaea BioLabs and Agility Life Sciences team up

Inaphaea BioLabs welcomes Dr Gareth Griffiths

Inaphaea laboratory

Inaphaea BioLabs: the journey to setting up a new laboratory

News roundup

ValiRx news roundup: July 2023